Dr. Bunnel Kitete Tunda  – Pharmacology – Best Researcher Award

Dr. Bunnel Kitete Tunda  -Pharmacology- Best Researcher Award

Federal University of São João del-Rei - Brazil

Author Profile 

SCOPUS

Early academic pursuits 🎓

Kitete Tunda Bunnel's academic journey began with a deep passion for medicine, pursuing a degree in human medicine from universite technologique bel campus (utbc) in the dr congo. graduating in 2012, his final thesis focused on the incidence of hypertensive retinopathy in patients, a topic that highlights his early interest in the intersections of chronic diseases and their impact on public health. this solid foundation laid the groundwork for his future contributions to healthcare, especially in geriatric pharmacology and drug utilization.

Professional endeavors 🏥

Kitete’s professional career spans across various continents, bringing his medical expertise from africa to brazil. after his graduation, he embarked on a journey that saw him transition to advanced studies in brazil, where he is currently pursuing a master's degree at universidade federal de são joão del-rei (ufsj). his master's research explores deprescribing oral antidiabetics in elderly patients, a critical topic given the global rise in aging populations and diabetes management. his diverse educational background, supplemented by short courses from renowned institutions like uppsala university in sweden, showcases his commitment to continuous learning and professional development.

Contributions and research focus 🔬

Kitete's research has been dedicated to understanding and improving the health outcomes of vulnerable populations, particularly the elderly. his master's thesis focuses on how oral antidiabetic medications are addressed in informational leaflets globally, an essential study given the growing importance of patient education Pharmacology and safety in medication usage. in addition to his research in pharmacology, kitete has made contributions to understanding chronic diseases like hypertension and diabetes, particularly in african and brazilian contexts.

Accolades and recognition 🏅

Kitete’s academic and research efforts have been recognized through multiple opportunities for advanced study and training. he was awarded a scholarship by coordenação de aperfeiçoamento de pessoal de nível superior (capes) in brazil, a prestigious recognition of his academic potential and commitment to research in Pharmacology healthcare. his work in drug utilization research has also been strengthened by his participation in international courses, including those at uppsala university in sweden, further enhancing his credentials in the global healthcare landscape.

Impact and influence 🌍

Kitete’s work is deeply impactful, as it addresses critical health challenges faced by elderly populations, particularly in the areas of diabetes and chronic disease management. his research on deprescribing oral antidiabetics highlights the importance of re-evaluating medication use in older adults, which could lead to Pharmacology significant advancements in patient safety and healthcare outcomes. his contributions span both local and international settings, ensuring that his research findings have broad implications for public health across different regions.

Legacy and future contributions 🔮

As kitete tunda bunnel continues his academic and professional journey, his contributions to geriatric pharmacology and chronic disease management promise to leave a lasting legacy. his work is paving the way for safer and more effective treatment protocols for elderly patients, and his international experiences allow him to bridge healthcare knowledge across continents. with a clear focus on patient-centered care, kitete’s future research will likely continue to influence healthcare policies and improve quality of life for aging populations around the world.

Notable Publications

  • Title: Deprescribing oral antidiabetics in elderly patients: Do electronic leaflets across the world address it?
    Authors: Bunnel, K.T., Carvalho, S.J.E., Pereira, M.L., Couto, R.O., Baldoni, A.O.
    Journal: Exploratory Research in Clinical and Social Pharmacy (2024), Vol. 16, Article 100537
  • Title: Rosemary (Rosmarinus officinalis L.) improves biochemical outcomes in diabetes mellitus: A systematic review and meta-analysis of animal studies
    Authors: Oliveira, V.M., Silveira, L.R., Bunnel, K.T., Baldoni, N.R., do Couto, R.O.
    Journal: Advances in Traditional Medicine (2024)

Dr. Hui Jia – Tumor chemotherapy resistance – Best Researcher Award

Dr. Hui Jia - Tumor chemotherapy resistance - Best Researcher Award

Shenyang Medical College - China 

Author Profile 

SCOPUS 

Early academic pursuits 📚

Dr. Hui Jia's journey in traditional chinese medicine began with a solid academic foundation. she earned her bachelor of pharmacy from shenyang pharmaceutical university, which sparked her interest in natural medicine and pharmacology. pursuing further studies, she obtained a master’s degree in traditional chinese medicine from shaanxi university of traditional chinese medicine. in 2021, she completed her ph.d. in traditional chinese medicine from shenyang pharmaceutical university, where her research honed in on the bioactive compounds of medicinal herbs and their therapeutic potential.

Professional endeavors 🏛️

Dr. Jia is currently an associate professor at the school of traditional chinese medicine, shenyang medical college. she has played a key role in shaping the institution’s research focus on herbal medicines and natural products. her dedication to teaching and mentorship is evident, as she actively guides students in exploring the intricate mechanisms of traditional remedies, while leading significant research projects that address major health challenges like drug-resistant cancers.

Contributions and research focus 🔬

Dr. Hui jia’s primary research revolves around understanding the active ingredients of herbs and their molecular mechanisms, particularly in reversing drug Tumor chemotherapy resistance resistance. her work is centered on investigating the key protein targets of natural products. one of her significant contributions is her research on cimigenoside, a bioactive compound from cohosh, and its role in combating drug resistance in triple-negative breast cancer through the γ-secretase/nicd/notch-pxr axis. her innovative approach offers new insights into cancer treatment.

Accolades and recognition 🏅

Through her groundbreaking research, dr. jia has gained recognition in the scientific community. she has secured prestigious grants from both the national natural science foundation of china and liaoning province for her work on cancer drug resistance. her research projects reflect her excellence and leadership in the field of Tumor chemotherapy resistance traditional chinese medicine, addressing complex challenges in cancer treatment and advancing the potential of natural products as therapeutic agents.

Impact and influence 🌍

Dr. jia's research has far-reaching implications, particularly in the realm of cancer therapeutics. her work on γ-secretase inhibitors and their role in reversing drug resistance in triple-negative breast cancer highlights the importance of integrating traditional medicine with modern science. her studies provide new avenues for Tumor chemotherapy resistance treating difficult cancers, potentially transforming how drug resistance is managed in clinical settings.

Legacy and future contributions 🔮

with her deep-rooted passion for traditional chinese medicine, dr. hui jia is set to leave a lasting legacy in the field. her future contributions are expected to further bridge the gap between traditional herbal medicine and contemporary drug discovery. as she continues to explore the bioactive compounds of natural products and their mechanisms of action, her work will undoubtedly influence future generations of researchers and contribute to innovative cancer therapies.

Notable Publications 

  1. Atorvastatin ameliorates diabetic nephropathy through inhibiting oxidative stress and ferroptosis signaling
    Authors: Zhang, Y., Qu, Y., Cai, R., Ren, F., Zhou, M.-S.
    Journal: European Journal of Pharmacology, 2024, 976, 176699
  2. Inhibition of γ-secretase/Notch pathway as a potential therapy for reversing cancer drug resistance
    Authors: Feng, M., Santhanam, R.K., Xing, H., Zhou, M., Jia, H.
    Journal: Biochemical Pharmacology, 2024, 220, 115991
  3. The role of angiotensin II activation of yes-associated protein/PDZ-binding motif signaling in hypertensive cardiac and vascular remodeling
    Authors: Xu, Q., Zhuo, K., Zhang, X., Dong, J., Zhou, M.-S.
    Journal: European Journal of Pharmacology, 2024, 962, 176252
  4. Cardiac macrophages in maintaining heart homeostasis and regulating ventricular remodeling of heart diseases
    Authors: Kang, M., Jia, H., Feng, M., Zhang, L., Zhou, M.-S.
    Journal: Frontiers in Immunology, 2024, 15, 1467089
  5. Cigarette smoke-induced exosomal miR-221-3p facilitates M1 macrophage polarization via the STAT3 pathway in chronic obstructive pulmonary disease
    Authors: Jia, H., He, W., Wu, B., Wang, M., Xia, S.
    Journal: Aging, 2024, 16(17), pp. 12379–12391